Diclazuril (CAS 101831-37-2), C17H9Cl3N4O2, the formula weight is 407.64, the form is white or light yellow power, almost insoluble in water and ethanol.
Diclazuril has excellent effects on chicken tenderness, heap type, poisoning, Brinell, and giant Eimeria. After treatment, it can effectively control the occurrence and death of cecal coccidia, and even make diseased chicken coccidia eggs. The capsules all disappeared, which is an ideal coccidiostat. Diclazuril also efficient for rabbit liver coccidia and enterococcal.

Market Analysis and Insights: Global Diclazuril (CAS 101831-37-2) Market
The global Diclazuril (CAS 101831-37-2) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Diclazuril (CAS 101831-37-2) Scope and Segment
The global Diclazuril (CAS 101831-37-2) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diclazuril (CAS 101831-37-2) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2015 to 2020. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.

Segment by Type, the Diclazuril (CAS 101831-37-2) market is segmented into
95% Purity Type
98% Purity Type
99% Purity Type
Others

Segment by Application, the Diclazuril (CAS 101831-37-2) market is segmented into
Diclazuril Premix
Diclazuril Solution

Diclazuril (CAS 101831-37-2) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Diclazuril (CAS 101831-37-2) business, the date to enter into the Diclazuril (CAS 101831-37-2) market, Diclazuril (CAS 101831-37-2) product introduction, recent developments, etc.
The major vendors covered:
Shenlong Animal Pharm
Bamu Technology
Zhengmu Technology
Huangkang Animal Pharm
Tianjin Shengji
Huifeng Pharm
Zhongmu Lide Pharm
Tianhe Biology
Da Bei Nong
Da Hua Nong
Bayer
Biovet
Kepro
SMAPC
Zhengyu Pharm
Huve Pharma

Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Diclazuril (CAS 101831-37-2) markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Diclazuril (CAS 101831-37-2) market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.